Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Botanix Pharmaceuticals Limited (AU: BOT)

 
BOT Technical Analysis
5
As on 8th May 2025 BOT STOCK Price closed @ 0.46 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.27 & Strong Buy for SHORT-TERM with Stoploss of 0.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOTSTOCK Price

Open 0.45 Change Price %
High 0.47 1 Day 0.01 2.22
Low 0.45 1 Week 0.02 4.55
Close 0.46 1 Month 0.00 0.00
Volume 5793863 1 Year 0.30 187.50
52 Week High 0.52 | 52 Week Low 0.14
 
AU Australia Most Active Stocks
LKY 0.04 33.33%
DTR 0.04 %
SYA 0.02 0.00%
PLS 1.48 -3.90%
WCN 0.03 0.00%
KNB 0.08 0.00%
GOR 3.30 -0.30%
TLS 4.59 0.66%
SIG 3.01 1.69%
CPH 0.01 0.00%
 
AU Australia Top Gainers Stocks
VR1 0.02 100.00%
APV 0.02 100.00%
NRX 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
 
AU Australia Top Losers Stocks
SHP 0.00 -100.00%
SHP 0.00 -100.00%
SHP 0.00 -100.00%
SHP 0.00 -100.00%
EM2 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
 
 
BOT
Daily Charts		 BOT
Intraday Charts		 Whats New @
Bazaartrend		 BOT
Free Analysis
 
BOT Important Levels Intraday
RESISTANCE0.50
RESISTANCE0.49
RESISTANCE0.48
RESISTANCE0.47
SUPPORT0.45
SUPPORT0.44
SUPPORT0.43
SUPPORT0.42
 
BOT Forecast May 2025
Share
4th UP Forecast0.59
3rd UP Forecast0.55
2nd UP Forecast0.52
1st UP Forecast0.5
1st DOWN Forecast0.42
2nd DOWN Forecast0.4
3rd DOWN Forecast0.37
4th DOWN Forecast0.33
 
BOT Weekly Forecast
4th UP Forecast0.54
3rd UP Forecast0.51
2nd UP Forecast0.50
1st UP Forecast0.48
1st DOWN Forecast0.44
2nd DOWN Forecast0.42
3rd DOWN Forecast0.41
4th DOWN Forecast0.38
 
BOT Forecast2025
4th UP Forecast1.23
3rd UP Forecast0.98
2nd UP Forecast0.83
1st UP Forecast0.68
1st DOWN Forecast0.24
2nd DOWN Forecast0.09
3rd DOWN Forecast-0.06
4th DOWN Forecast-0.31
 
 
BOT Other Details
Segment EQ
Market Capital 59361664.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOT Address
BOT
 
BOT Latest News
 
Your Comments and Response on Botanix Pharmaceuticals Limited
 
BOT Business Profile
Botanix Pharmaceuticals Limited, a clinical stage synthetic cannabinoid pharmaceutical company, engages in the research and development of dermatology and antimicrobial products in Australia. Its product pipeline include BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase Ib clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in North Perth, Australia. Address: 50 Angove Street, North Perth, WA, Australia, 6006
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service